1 year return (CAGR)
113.53%
Trevi Therapeutics Inc Exchange (NASDAQ, USD)
TRVI
14.68
-0.21 (-1.47%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
62.57%
5 year return (CAGR)
43.74%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.99B
Price/Sales
-
Ent value
1.99B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 14.22 |
| Daily high | 14.26 |
| Daily low | 13.36 |
| Daily Volume | 2.12M |
| All-time high | 19.50 |
| 1y analyst estimate | 28.18 |
| Beta | 1.07 |
| EPS (TTM) | -0.33 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Mar 2026 |
Downside potential
Loading...
Downside potential data
| TRVI | S&P500 | |
| Current price drop from All-time high | -24.74% | -1.38% |
| Highest price drop | -95.45% | -56.47% |
| Date of highest drop | 23 Feb 2022 | 9 Mar 2009 |
| Avg drop from high | -62.18% | -10.68% |
| Avg time to new high | 65 days | 12 days |
| Max time to new high | 1599 days | 1805 days |
News
